Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1D-methylphenidate
(D01296)		----[1] 84 💬
2Methylphenidate
(D01296)		[1] Methylphenidate[2] Methylphenidate hydrochloride (D01296),
Methylphenidate 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[5] 6, 13, 34, 84, 113 💬
3Methylphenidate 10MG tablets
(D01296)		[1] Methylphenidate[2] Methylphenidate hydrochloride (D01296),
Methylphenidate 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 84 💬
4Methylphenidate hydrochloride
(D01296)		[1] Methylphenidate[2] Methylphenidate hydrochloride (D01296),
Methylphenidate 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[2] 6, 13 💬
5Methylphenidate modified release
(D01296)		[1] Methylphenidate[2] Methylphenidate hydrochloride (D01296),
Methylphenidate 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 13 💬
6Methylphenidate modified release 20 MG
(D01296)		[1] Methylphenidate[2] Methylphenidate hydrochloride (D01296),
Methylphenidate 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 13 💬
7Methylphenidate modified release 30 MG
(D01296)		[1] Methylphenidate[2] Methylphenidate hydrochloride (D01296),
Methylphenidate 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 13 💬
8Methylphenidate modified release 40 MG
(D01296)		[1] Methylphenidate[2] Methylphenidate hydrochloride (D01296),
Methylphenidate 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 13 💬
9Methylphenidate oral solution
(D01296)		[1] Methylphenidate[2] Methylphenidate hydrochloride (D01296),
Methylphenidate 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 206 💬
10Methylphenidate, fluoxetin, risperidone
(D01296)		[1] Methylphenidate[2] Methylphenidate hydrochloride (D01296),
Methylphenidate 💬 		[2] SLC6A2,
SLC6A3 💬 		[8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[2] 179, 206 💬